Literature DB >> 23386693

Long-term prospective population PK study in GIST patients--letter.

Etienne Chatelut, Peggy Gandia, Verena Gotta, Nicolas Widmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23386693     DOI： 10.1158/1078-0432.CCR-12-3445

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  6 in total

1.  Imatinib Pharmacokinetics in a Large Observational Cohort of Gastrointestinal Stromal Tumour Patients.

Authors:  Sheima Farag; Remy B Verheijen; J Martijn Kerst; Annemiek Cats; Alwin D R Huitema; Neeltje Steeghs
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447

2.  Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs.

Authors:  Evelina Cardoso; Chantal Csajka; Marie P Schneider; Nicolas Widmer
Journal:  Clin Pharmacokinet       Date:  2018-01       Impact factor: 6.447

Review 3.  Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.

Authors:  Huixin Yu; Neeltje Steeghs; Cynthia M Nijenhuis; Jan H M Schellens; Jos H Beijnen; Alwin D R Huitema
Journal:  Clin Pharmacokinet       Date:  2014-04       Impact factor: 6.447

4.  Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure.

Authors:  Sander Bins; Karel Eechoute; Jacqueline S L Kloth; Femke M de Man; Astrid W Oosten; Peter de Bruijn; Stefan Sleijfer; Ron H J Mathijssen
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447

Review 5.  Imatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose.

Authors:  Kim Westerdijk; Ingrid M E Desar; Neeltje Steeghs; Winette T A van der Graaf; Nielka P van Erp
Journal:  Br J Clin Pharmacol       Date:  2020-01-21       Impact factor: 4.335

6.  Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.

Authors:  Imke H Bartelink; Pierre M Bet; Nicolas Widmer; Monia Guidi; Erik Duijvelaar; Bram Grob; Richard Honeywell; Amanda Evelo; Ivo P E Tielbeek; Sue D Snape; Henrike Hamer; Laurent A Decosterd; Harm Jan Bogaard; Jurjan Aman; Eleonora L Swart
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.